T1 Tumor limited to the pancreas and size <2 cm T2 Tumor limited to the pancreas and size 2–4 cm T3 Tumor limited to the pancreas and size >4 cm or invading duodenum or bile duct T4 Tumor ...

She had been diagnosed as having metastatic pulmonary neuroendocrine ... tumors, is caused by secretion of 5-hydroxytryptamine, histamine or tachykinines into the systemic circulation by tumor cells.

Neuroendocrine tumors originate from cells found throughout the body and can affect most organ systems. They most often attack the lungs, gastrointestinal tract, gynecological tract and prostate.

In summary, neuroendocrine carcinoma of the extrahepatic biliary tracts is a very rare and highly malignantdisease with a poor prognosis. Although treatment strategies have not yet been ...

a CD3xDLL3 bispecific in phase 2 development for advanced or metastatic DLL3-expressing large-cell neuroendocrine carcinoma (NEC) of the lung, and MSD's MK-6070, a DLL3-targeting T-cell engager ...

The tumors begin in neuroendocrine cells – which have characteristics of nerve and hormone-producing cells – and can arise in multiple sites in the body, most often in the gastrointestinal ...

The US Food and Drug Administration (FDA) has granted clearance for Abdera Therapeutics' investigational new drug (IND) application to commence a Phase I clinical trial of ABD-147 for small cell ...

Claim your 7-day free trial now. NETs are heterogeneous tumors arising from the digestive tract’s neuroendocrine cells and other organs, such as the lung and pancreas. The approval comes before ...

Neuroendocrine prostate cancer (NEPC) is the most aggressive form of prostate ... and abnormal expression of neuroendocrine markers, along with small cell morphology.